Global Cholesterol Monitors Market Size study & Forecast, by Product Type (Single-sided COD Chip-On-Flex, Other Chip-On-Flex Types), by End-Users (Military, Medical, Aerospace, Electronics, Other Verticals) and Regional Analysis, 2022-2029

Global Cholesterol Monitors Market Size study & Forecast, by Product Type (Single-sided COD Chip-On-Flex, Other Chip-On-Flex Types), by End-Users (Military, Medical, Aerospace, Electronics, Other Verticals) and Regional Analysis, 2022-2029

Global Cholesterol Monitors Market is valued at approximately USD 2.34 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.4% over the forecast period 2022-2029. The cholesterol monitors are devices that are used to test the level of cholesterol in patients. The key factors driving the market growth are rising rates of obesity and a geriatric population in developed countries like the U.S., Germany, and France have accelerated the cases of patients who have high levels of bad cholesterol, requiring a daily upsurge in the demand for cholesterol monitoring products worldwide. Also, the global cholesterol monitor market is anticipated to increase as a result of the rising prevalence of cardiovascular disorders, a growing focus on early diagnosis, and the significantly increasing of cholesterol monitors.

According to World Obesity Organization, in India, there has been a rise in the prevalence of overweight; in year 2019-2020, 18.7% of adults, 20% men and 17.2% women were overweight which increased to 23%, 22%, and 24% respectively by 2020-21. As a result, rising obesity will create lucrative growth for the market. Also, rising awareness and adoption of preventive healthcare would crate lucrative opportunities for the market during forecast period. However, the lack of healthcare resources, an undertrained human resource, and strict safety regulations stifle market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Cholesterol Monitors Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the growing incidence of cardiovascular disorders, coupled with the rise in aging population, and increasing preference for self-monitoring devices. Europe is expected to grow with the highest CAGR during the forecast period, owing to factors such as growing awareness related to prevention and early diagnosis of diseases, increasing obesity rate and rising technological innovation which would create lucrative growth prospects for the global cholesterol monitors market across the Europe region.

Major market players included in this report are:
Roche Diagnostics
PTS Diagnostics
Omron Healthcare, Inc.
ACON Laboratories, Inc.
AccuTech LLC
Alere Inc.
Siemens
Medline Industries, Inc.
Abaxis, Inc.
ManthaMed

Recent Developments in the Market:
 In 2020, The FDA has given Esperion approval to market Nexlizet (bempedoic acid-ezetimibe), a cholesterol-lowering combo, to patients who have high cholesterol or established atherosclerotic cardiovascular disease and have completed their statin therapy.
 In 2022, A medicine Bemdac, that contains bempedoic acid, was launched by Zydus Lifesciences to treat high levels of bad cholesterol.

Global Cholesterol Monitors Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product Type, End-Users, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Single-sided COD Chip-On-Flex
Other Chip-On-Flex Types

By End-Users:
Military
Medical
Aerospace
Electronics
Other Verticals

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
ROLA
Rest of the World

Companies Mentioned

Roche Diagnostics
PTS Diagnostics
Omron Healthcare, Inc.
ACON Laboratories, Inc.
AccuTech LLC
Alere Inc.
Siemens
Medline Industries, Inc.
Abaxis, Inc.
ManthaMed


Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.